Singtel
Z74
ST Engineering
S63
Keppel
BN4
CapitaLandInvest
9CI
Wilmar Intl
F34
SG Stock MarketDetailed Quotes
HQXW IX BiopharmaW260718
- 0.002
- 0.0000.00%
10min DelayTrading Jan 21 10:05 CST
1.77MMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.002Pre Close0.00Turnover0.01052wk High0.00%Turnover Ratio883.34MShares0.00152wk Low--EPS TTM861.43KFloat Cap0.010Historical High0.00P/E (Static)430.72MShs Float0.001Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B100Lot Size--Div YieldTTM
IX BiopharmaW260718 Key Stats
EPS
According to the latest financial report of IX BiopharmaW260718, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: SGD
Quarterly
Loading...
FCF
Interested in knowing about IX BiopharmaW260718's free cash flow? The latest report shows it as -2.75M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: SGD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of IX BiopharmaW260718 shows that the company's current ratio is 1.38, indicating healthy liquidity.
Currency: SGD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of IX BiopharmaW260718, the quick ratio is 1.20, indicating that the company can meet its short-term debt obligations.
Currency: SGD
Quarterly
Loading...
ROE
Want to learn more about the financial health of IX BiopharmaW260718? The latest ROE figure is -14.78%, indicating that the company has stable profitability.
Currency: SGD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of IX BiopharmaW260718, the total asset return on investment (ROA) is -10.68%.
Currency: SGD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check IX BiopharmaW260718's latest financial report to see how their gross margin is doing - currently at -91.95%.
Currency: SGD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of IX BiopharmaW260718, the net profit margin is -1.39K%, which is a good sign for its profitability.
Currency: SGD
Quarterly
Loading...
Trending Stocks
SG High Dividend SG High Dividend
Singapore's high dividend stocks offer a compelling investment opportunity for those seeking to generate regular income while participating in the potential growth of some of the region's most stable companies. By understanding the benefits and challenges associated with these stocks and conducting thorough research before investing, individuals can effectively incorporate high dividend stocks into their investment strategy. Always consider consulting with financial advisors to tailor investments to your personal financial goals and risk tolerance. With the right approach, high dividend stocks can be a valuable addition to a well-rounded investment portfolio. Singapore's high dividend stocks offer a compelling investment opportunity for those seeking to generate regular income while participating in the potential growth of some of the region's most stable companies. By understanding the benefits and challenges associated with these stocks and conducting thorough research before investing, individuals can effectively incorporate high dividend stocks into their investment strategy. Always consider consulting with financial advisors to tailor investments to your personal financial goals and risk tolerance. With the right approach, high dividend stocks can be a valuable addition to a well-rounded investment portfolio.